Approach to the treatment of intestinal infectious diseases caused by Clostridium difficile;Přístupy k léčbě střevních infekcí vyvolaných Clostridium difficile

Klinicka Mikrobiologie a Infekcni Lekarstvi

Volumn 16, Issue 3, 2010, Pages 93-96

  Nyč, Otakar ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Antibiotics; Clostridium difficile; Metronidazole; Vancomycin

Indexed keywords

METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; HUMAN; INTESTINE INFECTION; RECURRENT DISEASE; CLOSTRIDIUM INFECTION;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; HUMANS; METRONIDAZOLE; VANCOMYCIN;

EID: 77955401042     PISSN: 1211264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Barlett JG. Narrative Review: The New Epidemic of Clostridium difficile - Associated Enteric Disease. Ann Intern Med. 2006;145:758-764.
2. Džupová O, Beneš J. Clostridium difficile a klostridiová kolitida: co je nového. Klin mikrobiol inf lek. 2008; 14(3):115-117.
3. Pepin J. Improving the Treatment of Clostridium difficile - Associated Disease: Where Should We Start? Clin Infect Dis. 2006;43.553-555.
4. Blossom DB, McDonald LC. The Challenges Posed by Reemerging Clostridium difficile Infection. Clin Infect Dis. 2007;45:223-227.
5. Denève C, Janoir C, Poilane I, Fantinato C, Collignon A New trends in Clostridium difficile virulence and pathogenesis. Int J Antimicrob Agents. 2009;33 Suppl 1:S24-8.
6. Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol. 2009;15(13):1554-80.
7. McPherson S, Rees CJ, Ellis R, Soo S, Panter SJ. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea. Dis Colon Rectum. 2006;49:640-645. (Pubitemid 43723812)
8. Hecht DW, Galang MA, Sambol SP, et al. In vitro activities of 15 antimicrobial agents against HO toxigenic Clostridium difficile clinical isolates collected from 1983 to 2004. Antimicrob Agents Chemother. 2007;51:2716-9.
9. Pelaez T, Alcala L, Alonso R, et al. Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother. 2002;46:1647-50.
10. Pepin J. Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic? Clin Infect Dis. 2008;46:1493-1498.
11. Musher DM, Aslam S. Treatment of Clostridium difficile colitis in the critical care setting. Crit Care Clin. 2008;24:279-91.
12. Health Protection Agency. Clostridium difficile infection : How to deal with problem. 2010. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1232006607827
13. Leclair MA, Allard C, Lesur O, Pépin J. Clostridium difficile infection in the intensive care unit. J Intensive Care Med. 2010;25(1):23-30.
14. Musher DM, Logan N, Bressler AM, Johnson DP, Rossignol JF. Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study. Clin Infect Dis. 2009;48:e41-6.
15. Lu CL, Liu CY, Liao CH, Huang YT, Wang HP, Hsueh PR. Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole. Int J Antimicrob Agents. 2010;35:311-312.
16. Bauer MP, van Dissel JT. Alternative strategies for Clostridium difficile infection. Int J Antimicrob Agents. 2009;33 Suppl 1:S51-56.
17. Merrigan MM, Sambol SP, Johnson S, Gerding DN. New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration. Int J Antimicrob Agents. 2009;33 Suppl 1:S46-50.
18. Van Nood E, Speelman P, Kuijper EJ, Keller JJ. Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveill. 2009:14(34).
19. Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, Gerding DN, Nichol G, Thomas WD Jr, Leney M, Sloan S, Hay CA, Ambrosino DM. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med. 2010;362:197-205.